CVS Health Pharmacy & Consumer Wellness — D&A increased by 2.0% to $404.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.6%, from $379.00M to $404.00M. Over 4 years (FY 2021 to FY 2025), Pharmacy & Consumer Wellness — D&A shows a downward trend with a -5.3% CAGR.
An increase often signals significant capital investment or recent acquisitions, while a decrease may indicate aging assets or reduced investment in infrastructure.
This metric represents the non-cash expense allocated to the pharmacy and consumer wellness segment for the wear and tea...
Standard across all capital-intensive retail and healthcare segments, comparable to 'Segment D&A' reported by peers in the pharmacy and retail sector.
cvs_segment_pharmacy_consumer_wellness_depreciation_and_amortization| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $488.75M | $488.75M | $488.75M | $472.25M | $472.25M | $472.25M | $472.25M | $387.25M | $387.25M | $387.25M | $387.25M | $388.00M | $389.00M | $387.00M | $379.00M | $384.00M | $389.00M | $396.00M | $404.00M |
| QoQ Change | — | +0.0% | +0.0% | -3.4% | +0.0% | +0.0% | +0.0% | -18.0% | +0.0% | +0.0% | +0.0% | +0.2% | +0.3% | -0.5% | -2.1% | +1.3% | +1.3% | +1.8% | +2.0% |
| YoY Change | — | — | — | — | -3.4% | -3.4% | -3.4% | -18.0% | -18.0% | -18.0% | -18.0% | +0.2% | +0.5% | -0.1% | -2.1% | -1.0% | +0.0% | +2.3% | +6.6% |